Imagyn is caught promoting unapproved uses of device on the Internet
This article was originally published in Clinica
The US FDA has admonished Imagyn Medical for promoting unapproved uses of its Ovation Falloposcopy System on its Internet website.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.